- |||||||||| osoresnontrine (BI 409306) / Boehringer Ingelheim
Trial primary completion date: Alzheimer Disease Proof of Concept Study With BI 409306 Versus Placebo (clinicaltrials.gov) - Jul 19, 2016 P2, N=288, Recruiting, Recruiting --> Completed | Trial primary completion date: Dec 2015 --> Apr 2016 Trial primary completion date: May 2017 --> Sep 2017
- |||||||||| Biomarker, Trial primary completion date: Down Syndrome Biomarker Initiative (DSBI) (clinicaltrials.gov) - Jul 19, 2016
P=N/A, N=12, Active, not recruiting, Trial primary completion date: May 2017 --> Sep 2017 Trial primary completion date: Jun 2016 --> Dec 2016
- |||||||||| Trial completion, Enrollment change, Trial primary completion date: Exploratory Study for the Validity of QuQu Scale (clinicaltrials.gov) - Jul 15, 2016
P=N/A, N=972, Completed, Not yet recruiting --> Recruiting | Trial primary completion date: May 2016 --> Sep 2016 Recruiting --> Completed | N=400 --> 972 | Trial primary completion date: Dec 2015 --> Mar 2016
- |||||||||| Trial completion, Trial primary completion date: PET Imaging in Chronic Traumatic Encephalopathy (clinicaltrials.gov) - Jun 23, 2016
P=N/A, N=6, Completed, Recruiting --> Completed | Trial primary completion date: Aug 2012 --> Aug 2015 Suspended --> Completed | Trial primary completion date: Sep 2016 --> Jun 2016
- |||||||||| Enrollment closed, Trial primary completion date: Post-Operative Delirium in Elderly Surgical Patients (clinicaltrials.gov) - Jun 12, 2016
P=N/A, N=200, Active, not recruiting, Active, not recruiting --> Completed Recruiting --> Active, not recruiting | Trial primary completion date: Aug 2016 --> May 2017
- |||||||||| Trial primary completion date: 18F-AV-1451 High Resolution Autopsy Study (clinicaltrials.gov) - May 31, 2016
P1, N=10, Recruiting, Recruiting --> Completed Trial primary completion date: Nov 2016 --> Jun 2017
- |||||||||| Trial completion, Phase classification, Enrollment change, Trial primary completion date: Bioavailability of Ubiquinol in Huntington Disease (clinicaltrials.gov) - May 27, 2016
P1, N=6, Completed, Trial primary completion date: Nov 2016 --> Jun 2017 Recruiting --> Completed | Phase classification: PN/A --> P1 | N=12 --> 6 | Trial primary completion date: Mar 2010 --> Jul 2012
- |||||||||| Trial termination: Music Therapy in Alzheimer's Disease (clinicaltrials.gov) - May 26, 2016
P=N/A, N=35, Terminated, Active, not recruiting --> Completed | Trial primary completion date: Dec 2016 --> Apr 2016 Completed --> Terminated
- |||||||||| donanemab (LY3002813) / Eli Lilly
Trial primary completion date: A Study of LY3002813 in Participants With Alzheimer's Disease (clinicaltrials.gov) - May 23, 2016 P1, N=100, Active, not recruiting, Active, not recruiting --> Completed | N=100 --> 65 Trial primary completion date: Sep 2016 --> Jan 2017
- |||||||||| Enrollment closed, Enrollment change: Actigraphy to MEasuRe Intensive Care Unit Activity (clinicaltrials.gov) - May 12, 2016
P=N/A, N=25, Active, not recruiting, Active, not recruiting --> Completed Recruiting --> Active, not recruiting | N=75 --> 25
- |||||||||| Trial primary completion date: Energy Metabolism and Cognitive Aging (clinicaltrials.gov) - May 12, 2016
P4, N=40, Recruiting, Recruiting --> Active, not recruiting | N=75 --> 25 Trial primary completion date: Dec 2015 --> Dec 2016
|